Cargando…

Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies

BACKGROUND: Sepsis and bacterial meningitis are major causes of mortality and morbidity in neonates and infants. Meropenem, a broad-spectrum antibiotic, is not licensed for use in neonates and infants below 3 months of age and sufficient information on its plasma and CSF disposition and dosing in ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Germovsek, Eva, Lutsar, Irja, Kipper, Karin, Karlsson, Mats O, Planche, Tim, Chazallon, Corine, Meyer, Laurence, Trafojer, Ursula M T, Metsvaht, Tuuli, Fournier, Isabelle, Sharland, Mike, Heath, Paul, Standing, Joseph F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005047/ https://www.ncbi.nlm.nih.gov/pubmed/29684147 http://dx.doi.org/10.1093/jac/dky128

Ejemplares similares

Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial
por: Lutsar, Irja, et al.
Publicado: (2020)

Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial
por: Lutsar, Irja, et al.
Publicado: (2011)

Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
por: Padari, Helgi, et al.
Publicado: (2016)

Comparison of two alternative study designs in assessment of medicines utilisation in neonates
por: Nellis, Georgi, et al.
Publicado: (2014)

Clinical parameters predicting failure of empirical antibacterial therapy in early onset neonatal sepsis, identified by classification and regression tree analysis
por: Metsvaht, Tuuli, et al.
Publicado: (2009)

Effect of early directed implementation of family-integrated care measures on colonisation with Enterobacteriaceae in preterm neonates in NICU
por: Parm, Ülle, et al.
Publicado: (2023)

Nuestro mero mole : breve historia de la comida mexicana
por: Flores y Escalante, Jesús
Publicado: (2013)

Correction to: Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
por: Germovsek, Eva, et al.
Publicado: (2018)

Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
por: Germovsek, Eva, et al.
Publicado: (2018)

Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?
por: Germovsek, Eva, et al.
Publicado: (2016)

Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill Patients
por: Liebchen, Uwe, et al.
Publicado: (2021)

Del mero corazón. Chulas fronteras (videograbación)
Publicado: (1980)

An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
por: Hill, Louise F., et al.
Publicado: (2020)

High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination
por: Metsvaht, Tuuli, et al.
Publicado: (2015)

182. Piperacillin/tazobactam (P/T) versus meropenem (Mero) for treatment of extended-spectrum beta-lactamase (ESBL)-producing E.coli and K. pneumoniae bloodstream infections (BSIs)
por: Cox, Alexandra L, et al.
Publicado: (2023)

Standardising neonatal and paediatric antibiotic clinical trial design and conduct: the PENTA-ID network view
por: Folgori, Laura, et al.
Publicado: (2019)

Quantification of Ploidy in Proteobacteria Revealed the Existence of Monoploid, (Mero-)Oligoploid and Polyploid Species
por: Pecoraro, Vito, et al.
Publicado: (2011)

Rigidez Aórtica por Ressonância Magnética Cardíaca: Ferramenta Prognóstica ou Mero Espectador?
por: Câmara, Sérgio Figueiredo, et al.
Publicado: (2022)

Global shortage of neonatal and paediatric antibiotic trials: rapid review
por: Thompson, Georgina, et al.
Publicado: (2017)

Population pharmacokinetics and pharmacodynamics of dobutamine in neonates on the first days of life
por: Hallik, Maarja, et al.
Publicado: (2020)

Draft Genome Sequence of Persistent Klebsiella grimontii AT013-Mero-001, Isolated from Human Feces
por: Bühler, Sarah, et al.
Publicado: (2021)

Calamene-Type Sesqui-, Mero-, and Bis-sesquiterpenoids from Cultures of Heimiomyces sp., a Basidiomycete Collected in Africa
por: Pfütze, Sebastian, et al.
Publicado: (2023)

A Novel Genetic Variant in the WFS1 Gene in a Patient with Partial Uniparental Mero-Isodisomy of Chromosome 4
por: Delvecchio, Maurizio, et al.
Publicado: (2021)

Antibiotic prescription preferences in paediatric outpatient setting in Estonia and Sweden
por: Lass, Jana, et al.
Publicado: (2013)

People living with HIV in Estonia: engagement in HIV care in 2013
por: Laisaar, Kaja-Triin, et al.
Publicado: (2016)

A Novel Method for Analysing Frequent Observations from Questionnaires in Order to Model Patient-Reported Outcomes: Application to EXACT® Daily Diary Data from COPD Patients
por: Germovsek, Eva, et al.
Publicado: (2019)

SARS-CoV-2 dual infection with Delta and Omicron variants in an immunocompetent host: a case report
por: Abroi, Aare, et al.
Publicado: (2022)

The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence
por: Barker, Charlotte I S, et al.
Publicado: (2023)

Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology()
por: Barker, Charlotte I.S., et al.
Publicado: (2014)

NEO E-vita—NEO era!
por: Jakob, Heinz, et al.
Publicado: (2022)

Curcumin-meropenem synergy in carbapenem resistant Klebsiella pneumoniae curcumin-meropenem synergy
por: Gülen, Dumrul, et al.
Publicado: (2021)

Laboratory markers to determine clinical significance of coagulase-negative staphylococci in blood cultures
por: Mitt, Piret, et al.
Publicado: (2007)

Clinical equivalence with G-CSF biosimilars: methodologic approach in a (neo)adjuvant setting in non-metastatic breast cancer
por: Krendyukov, A., et al.
Publicado: (2017)

Prolonged outbreak of Serratia marcescens in Tartu University Hospital: a case–control study
por: Adamson, Vivika, et al.
Publicado: (2012)

Meropenem: continuous or extended infusion?
por: Frippiat, Frédéric, et al.
Publicado: (2020)

Meropenem: Leucopenia: case report
Publicado: (2021)

Single-dose pharmacokinetics of meropenem in porcine cancellous bone determined by microdialysis: An animal study
por: Hanberg, Pelle, et al.
Publicado: (2019)

Hospitalised neonates in Estonia commonly receive potentially harmful excipients
por: Lass, Jana, et al.
Publicado: (2012)

Peripheral blood RNA gene expression profiling in patients with bacterial meningitis
por: Lill, Margit, et al.
Publicado: (2013)

Surveillance of Gram-negative bacteria: impact of variation in current European laboratory reporting practice on apparent multidrug resistance prevalence in paediatric bloodstream isolates
por: Bielicki, J. A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9dmsopvgjfnnfb9up7r2j66a6r